Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: It is mostly ineffective, is expensive, and may rarely cause serious adverse events

Margaret S. Sozio, Naga Chalasani

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)1786-1788
Number of pages3
JournalHepatology
Volume60
Issue number5
DOIs
StatePublished - Nov 1 2014

Fingerprint

Hemorrhage
recombinant FVIIa

ASJC Scopus subject areas

  • Hepatology

Cite this

@article{aa97088423c84334a11bc230f6e6066e,
title = "Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: It is mostly ineffective, is expensive, and may rarely cause serious adverse events",
author = "Sozio, {Margaret S.} and Naga Chalasani",
year = "2014",
month = "11",
day = "1",
doi = "10.1002/hep.27363",
language = "English",
volume = "60",
pages = "1786--1788",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding

T2 - It is mostly ineffective, is expensive, and may rarely cause serious adverse events

AU - Sozio, Margaret S.

AU - Chalasani, Naga

PY - 2014/11/1

Y1 - 2014/11/1

UR - http://www.scopus.com/inward/record.url?scp=84927925181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927925181&partnerID=8YFLogxK

U2 - 10.1002/hep.27363

DO - 10.1002/hep.27363

M3 - Article

AN - SCOPUS:84927925181

VL - 60

SP - 1786

EP - 1788

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 5

ER -